1. Department of Pharmaceutical Sciences and
2. Department of Oncology, St. Jude Children’s Research Hospital, Memphis, TN;
3. Division of Hematology/Oncology, Boston Children’s Hospital, Harvard Medical School, Boston, MA;
4. Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA;
5. Department of Paediatrics, National University of Singapore, Singapore, Singapore;
6. Children’s Hospital of Fudan University, Shanghai, China;
7. Institutes of Biomedical Sciences, Fudan University, Shanghai, China;
8. Institute for Genomic Medicine, Nationwide Children’s Hospital, Columbus, OH;
9. Department of Pathology and
10. Department of Pediatrics, The Ohio State University, Columbus, OH;
11. Texas Children’s Cancer Center, Baylor College of Medicine, Houston, TX;
12. Department of Pediatrics, NYU Langone Medical Center, New York, NY;
13. Hematological Malignancies Program, Comprehensive Cancer Center, St. Jude Children’s Research Hospital, Memphis, TN;
14. Khoo Teck Puat-National University Children’s Medical Institute, National University Hospital, National University Health System, Singapore, Singapore;
15. VIVA-NUS Center for Translational Research in Acute Leukaemia, Department of Paediatrics, Yong Loo Lin School of Medicine, Singapore, Singapore;
16. Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore;
17. Department of Computational Biology and
18. Department of Global Pediatric Medicine, St. Jude Children’s Research Hospital, Memphis, TN;
19. Department of Pediatrics and Center for Childhood Cancer Research, Children’s Hospital of Philadelphia and the Perelman School of Medicine at The University of Pennsylvania, Philadelphia, PA;
20. Department of Pediatrics, Benioff Children's Hospital, San Francisco, CA; and
21. Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA